See more : Friedrich Vorwerk Group SE (FRVWY) Income Statement Analysis – Financial Results
Complete financial analysis of Tellgen Corporation (300642.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tellgen Corporation, a leading company in the Medical – Devices industry within the Healthcare sector.
- LianBio (LIANY) Income Statement Analysis – Financial Results
- Mediaset España Comunicación, S.A. (TL5.MC) Income Statement Analysis – Financial Results
- Shanghai Sunglow Packaging Technology Co.,Ltd (603499.SS) Income Statement Analysis – Financial Results
- Team Group Inc. (4967.TW) Income Statement Analysis – Financial Results
- Canadian Life Companies Split Corp. (CLSPF) Income Statement Analysis – Financial Results
Tellgen Corporation (300642.SZ)
About Tellgen Corporation
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 542.81M | 715.97M | 654.59M | 489.58M | 441.45M | 364.85M | 302.89M | 231.22M | 169.38M | 118.20M | 76.83M | 48.71M |
| Cost of Revenue | 188.58M | 307.57M | 217.00M | 164.53M | 94.60M | 78.69M | 58.88M | 44.65M | 31.46M | 21.90M | 14.63M | 10.31M |
| Gross Profit | 354.23M | 408.40M | 437.59M | 325.05M | 346.85M | 286.15M | 244.01M | 186.57M | 137.92M | 96.30M | 62.19M | 38.40M |
| Gross Profit Ratio | 65.26% | 57.04% | 66.85% | 66.39% | 78.57% | 78.43% | 80.56% | 80.69% | 81.43% | 81.47% | 80.95% | 78.84% |
| Research & Development | 77.72M | 79.33M | 72.71M | 61.47M | 51.99M | 40.00M | 29.65M | 21.77M | 18.13M | 18.63M | 9.95M | 0.00 |
| General & Administrative | 8.60M | 9.15M | 9.86M | 7.17M | 8.64M | 14.03M | 1.07M | 5.25M | 2.85M | 3.91M | 17.83M | 11.78M |
| Selling & Marketing | 175.52M | 194.58M | 181.39M | 124.22M | 111.37M | 83.27M | 66.67M | 45.53M | 37.16M | 26.66M | 19.62M | 13.44M |
| SG&A | 184.12M | 203.73M | 191.24M | 131.39M | 120.01M | 97.29M | 67.73M | 50.78M | 40.01M | 30.57M | 37.45M | 25.22M |
| Other Expenses | 0.00 | 17.49M | 27.36M | -354.87K | -671.28K | -74.46K | -27.22K | 7.16M | 4.57M | 1.87M | 2.00M | 2.39M |
| Operating Expenses | 265.87M | 308.12M | 291.15M | 196.05M | 177.91M | 133.84M | 103.23M | 80.62M | 65.27M | 54.39M | 38.17M | 25.56M |
| Cost & Expenses | 454.45M | 615.69M | 508.15M | 360.58M | 272.51M | 212.54M | 162.11M | 125.28M | 96.73M | 76.29M | 52.80M | 35.86M |
| Interest Income | 5.92M | 5.53M | 5.46M | 1.29M | 6.46M | 5.01M | 7.00M | 319.48K | 257.40K | 208.64K | 260.85K | 0.00 |
| Interest Expense | 726.15K | 741.11K | 1.11M | 135.28K | 18.25K | 662.16 | 354.66K | 595.49K | 818.95K | 974.27K | 0.00 | 0.00 |
| Depreciation & Amortization | 85.29M | 83.46M | 75.02M | 57.52M | 45.19M | 34.56M | 26.21M | 19.63M | 12.41M | 9.29M | 5.62M | 3.73M |
| EBITDA | 168.68M | 212.17M | 251.67M | 191.23M | 227.68M | 200.41M | 173.84M | 131.19M | 91.38M | 52.57M | 29.65M | 16.58M |
| EBITDA Ratio | 31.08% | 31.93% | 39.81% | 39.25% | 50.64% | 54.49% | 57.21% | 56.94% | 53.68% | 45.43% | 38.96% | 34.46% |
| Operating Income | 88.36M | 131.43M | 180.54M | 132.25M | 181.81M | 165.42M | 147.21M | 105.90M | 72.44M | 40.63M | 24.03M | 13.48M |
| Operating Income Ratio | 16.28% | 18.36% | 27.58% | 27.01% | 41.19% | 45.34% | 48.60% | 45.80% | 42.77% | 34.37% | 31.27% | 27.67% |
| Total Other Income/Expenses | -878.07K | -769.38K | -2.36M | -1.87M | -671.27K | -74.46K | -27.22K | 7.11M | 4.55M | 1.68M | 1.95M | 2.39M |
| Income Before Tax | 87.48M | 130.66M | 178.18M | 130.38M | 181.14M | 165.35M | 147.18M | 113.01M | 76.98M | 42.30M | 25.97M | 15.87M |
| Income Before Tax Ratio | 16.12% | 18.25% | 27.22% | 26.63% | 41.03% | 45.32% | 48.59% | 48.87% | 45.45% | 35.79% | 33.81% | 32.57% |
| Income Tax Expense | 2.79M | 6.92M | 17.12M | 9.82M | 24.13M | 23.66M | 20.37M | 15.24M | 11.21M | 6.30M | 3.40M | 2.25M |
| Net Income | 89.40M | 124.76M | 161.08M | 120.55M | 157.02M | 141.69M | 126.81M | 97.77M | 65.78M | 36.00M | 22.58M | 13.62M |
| Net Income Ratio | 16.47% | 17.42% | 24.61% | 24.62% | 35.57% | 38.84% | 41.87% | 42.28% | 38.83% | 30.46% | 29.39% | 27.96% |
| EPS | 0.55 | 0.77 | 0.99 | 0.74 | 0.97 | 0.87 | 0.85 | 0.80 | 0.54 | 0.30 | 0.19 | 0.00 |
| EPS Diluted | 0.55 | 0.77 | 0.98 | 0.74 | 0.97 | 0.87 | 0.85 | 0.80 | 0.54 | 0.30 | 0.19 | 0.00 |
| Weighted Avg Shares Out | 163.15M | 162.40M | 163.20M | 163.33M | 162.45M | 162.24M | 148.51M | 121.64M | 121.65M | 121.51M | 121.50M | 0.00 |
| Weighted Avg Shares Out (Dil) | 163.15M | 162.56M | 164.37M | 163.33M | 162.45M | 162.34M | 148.51M | 121.64M | 121.65M | 121.51M | 121.50M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports